secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2023-07-11T23:59:59+00:00
Accession:  0000320017-23-000037
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lisata Therapeutics announces retirement of director Erkki Ruoslahti; remains advisor
--------------------------------------------------------------------------------

- Dr. Erkki Ruoslahti resigned from the Board of Directors effective July 11, 2023.
- He will continue as a scientific advisor to the Company.
- Ruoslahti cited confidence in LSTA1 progress and reduced international travel as reasons.
- He is the scientific founder of the CendR Platform and a Lasker Prize winner.
- No replacement announced; board size unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000032001723000037/0000320017-23-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000032001723000037/clbs-20230711.htm
  HTML page:      https://secwatch.observer/filing/0000320017-23-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer